33 terminated. 33 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 33 | Terminated 33 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers RiduZone (90% OEA), Placebo - Overweight and Obesity | Phase 4 | Terminated | Yale University | 64 | 2021-04-06 | 2025-01-10 |
| EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial Weight Management Program (WMP), Traditional care, Phentermine / Topiramate Extended Release Oral Capsule - Type 2 Diabetes, Obesity | Phase 4 | Terminated | The Cleveland Clinic | 74 | 2020-09-01 | 2024-09-19 |
| Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients Dulaglutide Injection, Saline Injection - Stress Hyperglycemia | Phase 4 | Terminated | Emory University | 28 | 2019-03-08 | 2024-05-30 |
| Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy Administration of weight loss drug (Metformin or Topiramate) - Obesity | Phase 4 | Terminated | Hartford Hospital | 12 | 2019-03-01 | 2023-02-14 |
| Acute Labetalol Use in Preeclampsia Experimental labetalol dose, Current standard of care - Preeclampsia With Severe Features | Phase 4 | Terminated | Albany Medical College | 15 | 2019-02-18 | 2020-07-22 |
| The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia 162mg aspirin dose - Preeclampsia | Phase 4 | Terminated | Ohio State University | 152 | 2019-01-15 | 2024-04-29 |
| Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity Albuterol Sulfate, Interval Warm-up exercise - Asthma in Children, Obesity, Childhood | Phase 4 | Terminated | University of Nevada, Las Vegas | 34 | 2018-09-18 | 2021-07-22 |
| Metabolic Effects of Natriuretic Peptide Hormones recombinant human BNP(1-32), placebo (control, normal saline) - Obesity, Cardiovascular Physiological Phenomena | Phase 4 | Terminated | VA Office of Research and Development | 5 | 2018-07-01 | 2024-11-25 |
| Predictors of Lorcaserin-Induced Weight Loss Belviq, Placebo - Overweight and Obesity | Phase 4 | Terminated | Columbia University | 32 | 2018-01-03 | 2024-03-27 |
| Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years lorcaserin hydrochloride XR, Placebo - Obesity | Phase 4 | Terminated | Eisai Inc. | 278 | 2017-09-28 | 2021-07-19 |
| CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes canagliflozin, Placebo (for canagliflozin) - Diabetes Mellitus, Type 2, Obesity | Phase 4 | Terminated | The Cleveland Clinic | 16 | 2017-01-05 | 2020-11-20 |
| MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Lorcaserin, Metformin, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Terminated | University of North Carolina, Chapel Hill | 71 | 2016-09-01 | 2021-03-03 |
| Liraglutide for HIV-associated Neurocognitive Disorder Liraglutide - HIV Infection, Diabetes Mellitus Type 2 | Phase 4 | Terminated | Temple University | 4 | 2016-09-01 | 2022-07-29 |
| Naltrexone/Bupropion Cardiovascular Outcomes Study Naltrexone HCl/Bupropion HCl ER, Placebo - Obesity, Cardiovascular Diseases | Phase 4 | Terminated | Orexigen Therapeutics, Inc | 67 | 2016-01-01 | 2017-02-27 |
| Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy Ketofol, Propofol, Saline - Obesity, Bariatrics | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 22 | 2016-01-01 | 2020-02-11 |
| Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients Nephro Check Test, serum creatinine measurement - Acute Kidney Injury, Arterial Hypertension | Phase 4 | Terminated | Universitair Ziekenhuis Brussel | 100 | 2015-04-01 | 2018-10-15 |
| Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes Liraglutide, Observation alone - Type 2 Diabetes, Overweight | Phase 4 | Terminated | Centre Hospitalier Universitaire Dijon | 48 | 2014-02-04 | 2026-02-09 |
| The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine Metformin, Placebo (for metformin) - Schizophrenia | Phase 4 | Terminated | Seoul National University Hospital | 15 | 2012-09-01 | 2018-09-07 |
| Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section Silverlon, Standard Dressing - Obesity, Complications; Caesarean Section, Wound | Phase 4 | Terminated | University of Michigan | 37 | 2012-02-01 | 2017-04-04 |
| Liraglutide Use in Prader-Willi Syndrome Liraglutide - Diabetes Mellitus Type 2, Prader Willi Syndrome | Phase 4 | Terminated | Vancouver General Hospital | 1 | 2012-02-01 | 2015-12-09 |
Showing 20 of 33. Sign in to see all of them.
Obesity (29) · Diabetes Mellitus, Type 2 (6) · Cardiovascular Diseases (3) · Glucose Intolerance (3) · Metabolic Syndrome (3) · Weight Loss (3) · Hypertension (2) · Pediatric Obesity (2) · Schizophrenia (2) · Acute Kidney Injury (1) · Asthma, Exercise-Induced (1) · Attention Deficit Disorder with Hyperactivity (1) · Diabetes Mellitus (1) · Feeding Behavior (1)
Nutrition Disorders (33) · Nutritional and Metabolic Diseases (33) · Overnutrition (33) · Body Weight (32) · Pathological Conditions, Signs and Symptoms (32) · Signs and Symptoms (32) · Glucose Metabolism Disorders (12) · Metabolic Diseases (12) · Endocrine System Diseases (7) · Diabetes Mellitus (6) · Hyperinsulinism (4) · Body Weight Changes (3) · Hyperglycemia (3) · Insulin Resistance (3)
Liraglutide (4) · Metformin (3) · lorcaserin (3) · Orlistat (2) · Sodium Chloride (2) · Sugars (2) · Topiramate (2) · sibutramine (2) · Acarbose (1) · Adiposity (1) · Albuterol (1) · Caloric Restriction (1) · Canagliflozin (1) · Diet Therapy (1) · Diet, Carbohydrate-Restricted (1)
The Cleveland Clinic (2) · Yale University (2) · Albany Medical College (1) · Centre Hospitalier Universitaire Dijon (1) · Columbia University (1) · Duke University (1) · Eisai Inc. (1) · Emory University (1) · Fundación Cardiovascular de Colombia (1) · Hartford Hospital (1) · Hopital Foch (1) · Icahn School of Medicine at Mount Sinai (1) · New York State Psychiatric Institute (1) · Northwell Health (1) · Ohio State University (1)
United States (24) · Canada (2) · France (2) · Belgium (1) · Colombia (1) · Denmark (1) · South Korea (1) · United Kingdom (1)
Alan Ettinger, MD (1) · Alicia L Warnock, MD (1) · Angela Liang, MD (1) · Arne V Astrup, phD.MD (1) · Bartolome Burguera (1) · Cherie Vaz, MD Dipl ABOM (1) · Daniel J Katz, MD (1) · David A Maerz, MD (1) · David L Russell-Jones, MBBS,MD,FRCP (1) · Dharini M Bhammar, Ph.D. (1) · Donna H Ryan, MD (1) · Federico A Silva, MD (1) · Francisco Pasquel, MD, MPH (1) · Gustavo Marques, MD (1) · James AS Muldowney, MD (1)
PMID 16959033, PMID 20101009, PMID 21962313, PMID 22445512, PMID 25500680, PMID 25611642, PMID 31405666, PMID 35967820, PMID 36897161, PMID 38686535, PMID 42668311
K23DK074439 (1), K23GM128221 (1), R01DK093920 (1), R01DK105526 (1), R01DK126295 (1)